Abstract: Embodiments of the disclosure relate to an optical fiber cable. The optical fiber cable includes a cable jacket having an inner surface and an outer surface in which the inner surface defines a central bore along a longitudinal axis of the optical fiber cable and the outer surface defines the outermost extent of the cable. The optical fiber cable also includes at least one access feature disposed in the cable jacket between the inner surface and the outer surface. Further included are a first plurality of optical fiber bundles. Each optical fiber bundle includes a second plurality of optical fiber ribbons that has a third plurality of optical fibers arranged in a planar configuration. The optical fiber cable bends uniformly in all directions transverse to the longitudinal axis of the optical fiber cable.

Abstract: Disclosed herein are compositions and methods of treating disclosure provides for compounds for use in treating Mitochondrial Neurogastrointestinal Encephalopathy Syndrome (MNGIE). In some embodiments, the compounds have cell penetrating activity and thymidine phosphorylase activity. In certain embodiments, the compounds disclosed herein comprise: a) at least one cell-penetrating peptide (CPP) moiety; and b) a thymidine phosphorylase, or an active fragment or analog thereof (TP), wherein the CPP is coupled, directly or indirectly, to TP.

Abstract: Disclosed herein are compositions and methods of treating disclosure provides for compounds for use in treating Mitochondrial Neurogastrointestinal Encephalopathy Syndrome (MNGIE). In some embodiments, the compounds have cell penetrating activity and thymidine phosphorylase activity. In certain embodiments, the compounds disclosed herein comprise: a) at least one cell-penetrating peptide (CPP) moiety; and b) a thymidine phosphorylase, or an active fragment or analog thereof (TP), wherein the CPP is coupled, directly or indirectly, to TP.

Abstract: Disclosed herein are compositions and methods of treating disclosure provides for compounds for use in treating Mitochondrial Neurogastrointestinal Encephalopathy Syndrome (MNGIE). In some embodiments, the compounds have cell penetrating activity and thymidine phosphorylase activity. In certain embodiments, the compounds disclosed herein comprise: a) at least one cell-penetrating peptide (CPP) moiety; and b) a thymidine phosphorylase, or an active fragment or analog thereof (TP), wherein the CPP is coupled, directly or indirectly, to TP.

Abstract: The present invention generally relates to therapeutic inhibition of protein arginine methyltransferase 5 (PRMT5). In particular, cell lines having MTAP loss and increased intracellular MTA concentrations show selective dependence on PRMT5. Thus, the invention also relates to methods of identifying and treating PRMT5-related diseases in subjects or tissues which have an MTAP deficiency, alone or in combination, with a second agent that reduces MTAP activity and/or increases intracellular MTA levels, and/or provides an MTA analogs to the cell or tissue. The invention also relates to the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas System and components thereof. More specifically, the present invention relates to the delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions in tumor cells ex vivo and/or in vivo. For example using methods disclosed herein, cells can be sensitized to PRMT5 inhibition.

Abstract: A cable clamp for securing an electrical cable to a support structure has two substantially similar half-shells, each half-shell including a concave inner surface terminating in a pair of abutting surfaces. The half-shells further include a pair of winged flanges offset a distance from the abutting surfaces. The lower half-shell can first be secured to a support structure using a pair of elongate members passing through the winged flanges of the lower half-shell and a plurality of fastening members. A cable can then be placed within a cable receiving region of the lower half-shell and the top half-shell can be secured to the lower half-shell, applying a clamping force to the cable without interference from the fastening members used to secure the lower half-shell to the support structure.

Abstract: A cable clamp for securing an electrical cable to a support structure has two substantially similar half-shells, each half-shell including a concave inner surface terminating in a pair of abutting surfaces. The half-shells further include a pair of winged flanges offset a distance from the abutting surfaces. The lower half-shell can first be secured to a support structure using a pair of elongate members passing through the winged flanges of the lower half-shell and a plurality of fastening members. A cable can then be placed within a cable receiving region of the lower half-shell and the top half-shell can be secured to the lower half-shell, applying a clamping force to the cable without interference from the fastening members used to secure the lower half-shell to the support structure.